Literature DB >> 3426298

Association of persisting IgA response with yersinia triggered reactive arthritis: a study on 104 patients.

A Toivanen1, R Lahesmaa-Rantala, R Vuento, K Granfors.   

Abstract

Twelve to 16 months after Yersinia enterocolitica O:3 enteritis 33 (85%) of the 39 patients who developed reactive arthritis as a postinfection complication had IgA class and 28 (72%) had IgG class anti-yersinia antibodies. In contrast, 7 (32%) of the 22 patients who did not develop arthritis were positive in the IgA test and 11 (50%) positive in the IgG test. The results were about the same when the material was divided into cases with diagnosis of yersiniosis verified by stool culture or by serology. These results confirm the value of enzyme linked immunosorbent assay (ELISA) in the diagnosis of yersiniosis, particularly in cases with postinfection complications when the stool isolations remain negative.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426298      PMCID: PMC1003419          DOI: 10.1136/ard.46.12.898

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Is the incidence of Yersinia enterocolitica infection increasing?

Authors:  P Toivanen; A Toivanen; L Olkkonen; S Aantaa
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-04

2.  Susceptibility and HLA-B27 in post-dysenteric arthropathies.

Authors:  C G van Bohemen; R J Lionarons; P van Bodegom; H J Dinant; J E Landheer; A J Nabbe; F C Grumet; H C Zanen
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

3.  Diagnosis of human brucellosis with ELISA.

Authors: 
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

4.  What do serum antibodies to Yersinia enterocolitica indicate?

Authors:  S Lange; P Larsson
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

5.  Common serological features in rheumatoid arthritis and yersinia arthritis. Demonstration of rheumatoid factors and antibodies against ssDNA and Yersinia enterocolitica Lipopolysaccharide by ELISA.

Authors:  M Gripenberg
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

Review 6.  Yersinia enterocolitica septicemia: clinical and microbiological aspects.

Authors:  U Foberg; A Frydén; E Kihlström; K Persson; O Weiland
Journal:  Scand J Infect Dis       Date:  1986

7.  Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis.

Authors:  K Granfors; M Viljanen; A Tiilikainen; A Toivanen
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Measurement of immunoglobulin M, immunoglobulin G, and immunoglobulin A antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: comparison of lipopolysaccharide and whole bacterium as antigen.

Authors:  K Granfors; M K Viljanen; A Toivanen
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

9.  HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.

Authors:  A Trull; A Ebringer; G Panayi; R Ebringer; D C James
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  Antibodies against Yersinia enterocolitica in patients with Reiter's syndrome.

Authors:  S Kobayashi; M Ogasawara; K Maeda; D T Yu
Journal:  J Lab Clin Med       Date:  1985-03
View more
  21 in total

Review 1.  Pathogenesis of reactive arthritis.

Authors:  J Sieper
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

2.  Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?

Authors:  S Bas; C Scieux; T L Vischer
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Antibodies to the peptide from the plasmid-coded Yersinia outer membrane protein (YOP1) in patients with ankylosing spondylitis.

Authors:  N Tsuchiya; G Husby; R C Williams
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 4.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 5.  Epidemic reactive arthritis.

Authors:  C J Eastmond
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

6.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

7.  Synovial T lymphocyte recognition of organisms that trigger reactive arthritis.

Authors:  J S Gaston; P F Life; K Granfors; R Merilahti-Palo; L Bailey; S Consalvey; A Toivanen; P A Bacon
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

8.  Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy.

Authors:  J A Hoogkamp-Korstanje; J de Koning; J Heesemann; J J Festen; P M Houtman; P L van Oyen
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

Review 9.  Immunological and bacteriological aspects of reactive arthritis.

Authors:  A Toivanen; K Granfors; R Lahesmaa-Rantala; P Toivanen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

Review 10.  Implications for persistent chlamydial infections of phagocyte-microorganism interplay.

Authors:  I Sarov; E Geron; Y Shemer-Avni; E Manor; M Zvillich; D Wallach; E Schmitz; H Holtman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.